ArticleEULAR rheumatology open2025
How should we manage patients with interferon-gamma release assay-positive results in rheumatology: assessing the risk and long-term prognosis of tuberculosis.
Article in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nontuberculous mycobacterium seroprevalence in Japanese patients with RA.Rheumatology advances in practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Tuberculosis (TB) is a global health problem. Screening for latent TB infection (LTBI) and the administration of preventive treatment in populations at high risk of developing TB are considered crucial. Although patients with rheumatic diseases are at high risk, there are few reports on the screening, prevalence, treatment, and prognosis of LTBI in this setting. In this study, we investigated the characteristics of patients with LTBI in a rheumatology department in Japan. Methods: We collected interferon-gamma release assay (IGRA) results and patient information from the medical records of patients who attended the rheumatology department at National Hospital Organization Sagamihara National Hospital (Sagamihara, Japan) from 2013 to 2022. Results: Of 4072 patients tested with IGRA, 157 were positive (3.9%). The rates of IGRA positivity decreased with time ( Conclusions: In IGRA-positive patients, it is important to perform mycobacterial and imaging tests, as well as long-term follow-up.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.